Tridione (AbbVie Inc.)


Welcome to the PulseAid listing for the Tridione drug offered from AbbVie Inc.. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: AbbVie Inc.
NON-PROPRIETARY NAME: Trimethadione
SUBSTANCE NAME: TRIMETHADIONE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
ROUTE: ORAL
DOSAGE FORM: TABLET, CHEWABLE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1946-01-25
END MARKETING DATE: 0000-00-00


Tridione HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTridione from AbbVie Inc.
LABELER NAME: AbbVie Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 150(mg/1)
START MARKETING DATE: 1946-01-25
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0074-3753_78cb2405-3427-9c89-c252-9fa5dba1a177
PRODUCT NDC: 0074-3753
APPLICATION NUMBER: NDA005856

Other TRIMETHADIONE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AbbVie Inc.Tridione